INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.

Medical Freedom Maps

Home » Maps » Regenerative medicine » North Carolina

Regenerative medicine in North Carolina

Regenerative medicine laws and requirements in North Carolina. Citations, verification dates, and source links for every data point.

DimensionValueCitationSourceVerifiedConfidence
Permit Unapproved Cell Therapiespermit cell therapiesN.C. Gen. Stat. § 90-325.1 et seq. (Right to Try Act, as amended by H.B. 934, 2019)“The North Carolina SCI Medical Freedom law [H.934 (2019)] amended the State’s RTT Act (NC G.S.§90–325.1–2, 6–7) and added a new section (NC G.S.§90–325.15–22) to allow patients access to investigational stem cell therapies.”Note: Access to investigational adult stem cell treatments (in clinical trials, not FDA approved) for severe chronic disease or terminal illness. Official NC statute site (ncleg.gov) blocked automated access (403/Cloudflare) during this pass; evidence is a peer-reviewed review. Primary text not read.Link2026-10-09medium
Require Patient Disclosure for Cell Therapiesrequire disclosureN.C. Gen. Stat. § 90-325.1 et seq. (H.B. 934, 2019)“Written informed consent must include an explanation of currently approved treatments for the patient’s illness; attestation that patient believes current treatments are insufficient; identification of the specific class of investigational SCI;”Note: Statutory written informed consent; no posted/advertising notice. Official NC statute site (ncleg.gov) blocked automated access (403/Cloudflare) during this pass; evidence is a peer-reviewed review. Primary text not read.Link2026-10-09medium
Limit Practitioner Scope for Cell TherapiesPhysician must administer; protocol approved by an IRB (affiliated with a medical school or its affiliated facility), with annual IRB reports to the NC Medical Board.N.C. Gen. Stat. § 90-325.1 et seq. (H.B. 934, 2019)“The law requires that a physician administers the SCI, that the protocol be approved by an IRB, and that an annual report be sent to the state medical board by the IRB.”Note: IRB affiliation detail from the review's Table 2 ('IRB must be affiliated with a medical school or an affiliated facility of a medical school'). Official NC statute site (ncleg.gov) blocked automated access (403/Cloudflare) during this pass; evidence is a peer-reviewed review. Primary text not read.Link2026-10-09medium
Have Cell Therapy Statute ReferencesN.C. Gen. Stat. § 90-325.1 et seq. (Right to Try Act, as amended by H.B. 934, 2019)N.C. Gen. Stat. § 90-325.1 et seq.“The North Carolina SCI Medical Freedom law [H.934 (2019)] amended the State’s RTT Act (NC G.S.§90–325.1–2, 6–7) and added a new section (NC G.S.§90–325.15–22) to allow patients access to investigational stem cell therapies.”Note: Exact section numbers of the stem cell part could not be confirmed from the official site (sources differ); cite the Act generally. Official NC statute site (ncleg.gov) blocked automated access (403/Cloudflare) during this pass; evidence is a peer-reviewed review. Primary text not read.Link2026-10-09medium

View full North Carolina profile (all layers) · Report an error on this page

Methodology: every value was checked in October 2026 against a specific source (statute, regulator or official list, or a named tracker page), and each links to that page with a short quote. Values no source could support are shown as “Not verified”. Verification was AI-assisted and spot-checked; laws change, so confirm with the linked source before relying on a value. How values are verified · Report an error.